Evotec Nominates Industry Veteran Dieter Weinand as Supervisory Board Chairman

Evotec SE's Supervisory Board has officially nominated Dieter Weinand to serve as its next Chairman, marking a significant leadership transition. The formal election is scheduled to take place during the company's Annual General Meeting on June 11, 2026. Weinand brings a wealth of expertise to the role, backed by over 30 years of global pharmaceutical industry experience in both leadership and operational capacities. This strategic nomination is intended to strengthen the company’s leadership framework to better support high-level partnerships and commercial execution. Furthermore, the move is designed to bolster Evotec's ongoing transformation strategy and its intensified focus on achieving long-term profitability. Analysts view the appointment of such an experienced industry veteran as a positive step for corporate governance and the company's future strategic direction.